Join to View Full Profile
2050 Kenny RdFl 8Columbus, OH 43221
Phone+1 614-293-5066
Fax+1 614-293-9449
Dr. Mittra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2015 - 2018
Texas Health Resources (Dallas)Residency, Internal Medicine, 2012 - 2015
Terna Medical CollegeClass of 2008
Certifications & Licensure
OH State Medical License 2020 - 2026
FL State Medical License 2015 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP.Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho, Daniel Stover, Ramesh K Ganju
Cancer Biology & Therapy. 2025-12-01 - Hospital admission during neoadjuvant therapy for pancreatic ductal adenocarcinoma: prevalence, predictors, and prognosis.Patrick W Underwood, Thomas Leuschner, Amanda K Walsh, Eric D Miller, Kenneth L Pitter
HPB. 2025-08-29 - Safety and Tolerability of Berzosertib, an Ataxia-Telangiectasia-Related Inhibitor, and Veliparib, an Oral Poly (ADP-ribose) Polymerase Inhibitor, in Combination With ...Geraldine O'Sullivan Coyne, Khanh T Do, Shivaani Kummar, Sarina Piha-Paul, Lawrence Rubinstein
JCO Precision Oncology. 2025-07-01
Lectures
- Safety and tolerability of veliparib, an oral PARP inhibitor, and M6620 (VX-970), an ATR inhibitor, in combination with cisplatin in patients with refractory solid tum...2019 ASCO Annual Meeting - 6/1/2019
- Pregnancies in subjects on oncology clinical trials: Analysis from the Cancer Therapy Evaluation Program (CTEP) database.2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
How Ohio State Experts Are Taking on the Challenges of Pancreatic CancerNovember 27th, 2024
Grant Support
- A phase-1 trial of intraperitoneal 5-fluorouracil and oxaliplatin in patients with colorectal cancer and unresectable peritoneal metastasis.OHIO STATE UNIVERSITY2023–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
